talactoferrin alfa has been researched along with Hemorrhagic Shock in 1 studies
talactoferrin alfa: recombinant human lactoferrin, an oral drug for treatment of refractory solid tumors; in Phase I trial 5/2006
Excerpt | Relevance | Reference |
---|---|---|
"These results provide a proof of principle that prophylactic dosing of oral talactoferrin can potentially protect the gut in a T/HS model and limit the production of biologically active factors in rat gastrointestinal tissue subjected to ischemia-reperfusion-type injuries." | 7.80 | Oral pretreatment with recombinant human lactoferrin limits trauma-hemorrhagic shock-induced gut injury and the biological activity of mesenteric lymph. ( Chandler, B; Deitch, EA; Feketova, E; Qin, Y; Quackenbush, EJ; Son, JY, 2014) |
"These results provide a proof of principle that prophylactic dosing of oral talactoferrin can potentially protect the gut in a T/HS model and limit the production of biologically active factors in rat gastrointestinal tissue subjected to ischemia-reperfusion-type injuries." | 3.80 | Oral pretreatment with recombinant human lactoferrin limits trauma-hemorrhagic shock-induced gut injury and the biological activity of mesenteric lymph. ( Chandler, B; Deitch, EA; Feketova, E; Qin, Y; Quackenbush, EJ; Son, JY, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Son, JY | 1 |
Chandler, B | 1 |
Feketova, E | 1 |
Qin, Y | 1 |
Quackenbush, EJ | 1 |
Deitch, EA | 1 |
1 other study available for talactoferrin alfa and Hemorrhagic Shock
Article | Year |
---|---|
Oral pretreatment with recombinant human lactoferrin limits trauma-hemorrhagic shock-induced gut injury and the biological activity of mesenteric lymph.
Topics: Administration, Oral; Animals; Ileum; Lactoferrin; Laparotomy; Lymph; Lymphatic System; Male; Neutro | 2014 |